10X genomics, INC.:1279204 [23-003679]

Ended Awarded Last action

Contract number
75N92B23F90032
Awardee
Awarding agency
Obligated
$24,324

Award facts

Contract value 100% obligated
$24,324.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a BPA call to 10X Genomics, Inc. for Chromium Next GEM Single Cell 3' Kit, V3.1 reagents (16 reactions) on April 13, 2022, with a ceiling value of $24,324.00. Performance occurs in Pleasanton, California, with completion by January 31, 2024. The call was issued under firm fixed price terms with no set-aside.

Quick answers

Who was awarded contract 75N92B23F90032?

75N92B23F90032 was awarded to 10X Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on April 13, 2022.

How much is contract 75N92B23F90032 worth?

The government has obligated $24,324 on 75N92B23F90032.

Is contract 75N92B23F90032 an order under another contract?

Yes. 75N92B23F90032 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92B23F90032 competed?

The extent of competition for 75N92B23F90032 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login